Ductal barriers in mammary epithelium

References

• Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. 2010 [cited; Available from: http://globocan.iarc.fr
   Google Scholar
• Brennan K, Offiah G, McSherry EA, Hopkins AM. Tight junctions: a barrier to the initiation and progression of breast cancer?. J Biomed Biotechnol 2010; 2010:460607; http://dx.doi.org/10.1155/2010/460607; PMID: 19920867
   PubMed Web of Science ®Google Scholar
• Ramsay DT, Kent JC, Hartmann RA, Hartmann PE. Anatomy of the lactating human breast redefined with ultrasound imaging. J Anat 2005; 206:525 - 34; http://dx.doi.org/10.1111/j.1469-7580.2005.00417.x; PMID: 15960763
   PubMedGoogle Scholar
• Guinebretière JM, Menet E, Tardivon A, Cherel P, Vanel D. Normal and pathological breast, the histological basis. Eur J Radiol 2005; 54:6 - 14; http://dx.doi.org/10.1016/j.ejrad.2004.11.020; PMID: 15797289
   PubMedGoogle Scholar
• Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 2004; 286:C1213 - 28; http://dx.doi.org/10.1152/ajpcell.00558.2003; PMID: 15151915
   PubMed Web of Science ®Google Scholar
• Green KJ, Getsios S, Troyanovsky S, Godsel LM. Intercellular junction assembly, dynamics, and homeostasis. Cold Spring Harb Perspect Biol 2010; 2:a000125; http://dx.doi.org/10.1101/cshperspect.a000125; PMID: 20182611
   PubMed Web of Science ®Google Scholar
• Meng W, Takeichi M. Adherens junction: molecular architecture and regulation. Cold Spring Harb Perspect Biol 2009; 1:a002899; http://dx.doi.org/10.1101/cshperspect.a002899; PMID: 20457565
   PubMed Web of Science ®Google Scholar
• Brooke MA, Nitoiu D, Kelsell DP. Cell-cell connectivity: desmosomes and disease. J Pathol 2012; 226:158 - 71; http://dx.doi.org/10.1002/path.3027; PMID: 21989576
   PubMed Web of Science ®Google Scholar
• Basham KJ, Kieffer C, Shelton DN, Leonard CJ, Bhonde VR, Vankayalapati H, Milash B, Bearss DJ, Looper RE, Welm BE. Chemical genetic screen reveals a role for desmosomal adhesion in mammary branching morphogenesis. J Biol Chem 2013; 288:2261 - 70; http://dx.doi.org/10.1074/jbc.M112.411033; PMID: 23212921
   PubMedGoogle Scholar
• Pitelka DR, Hamamoto ST, Duafala JG, Nemanic MK. Cell contacts in the mouse mammary gland. I. Normal gland in postnatal development and the secretory cycle. J Cell Biol 1973; 56:797 - 818; http://dx.doi.org/10.1083/jcb.56.3.797; PMID: 4569313
   PubMed Web of Science ®Google Scholar
• Warburton MJ, Mitchell D, Ormerod EJ, Rudland P. Distribution of myoepithelial cells and basement membrane proteins in the resting, pregnant, lactating, and involuting rat mammary gland. J Histochem Cytochem 1982; 30:667 - 76; http://dx.doi.org/10.1177/30.7.6179984; PMID: 6179984
   PubMed Web of Science ®Google Scholar
• Davies EL, Gee JM, Cochrane RA, Jiang WG, Sharma AK, Nicholson RI, Mansel RE. The immunohistochemical expression of desmoplakin and its role in vivo in the progression and metastasis of breast cancer. Eur J Cancer 1999; 35:902 - 7; http://dx.doi.org/10.1016/S0959-8049(99)00031-3; PMID: 10533469
   PubMedGoogle Scholar
• Maynadier M, Chambon M, Basile I, Gleizes M, Nirde P, Gary-Bobo M, Garcia M. Estrogens promote cell-cell adhesion of normal and malignant mammary cells through increased desmosome formation. Mol Cell Endocrinol 2012; 364:126 - 33; http://dx.doi.org/10.1016/j.mce.2012.08.016; PMID: 22963885
   PubMed Web of Science ®Google Scholar
• Lu M, Mira-y-Lopez R, Nakajo S, Nakaya K, Jing Y. Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells. Oncogene 2005; 24:4362 - 9; http://dx.doi.org/10.1038/sj.onc.1208661; PMID: 15870697
   PubMedGoogle Scholar
• Zhu WY, Jones CS, Amin S, Matsukuma K, Haque M, Vuligonda V, Chandraratna RA, De Luca LM. Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells. Cancer Res 1999; 59:85 - 90; PMID: 9892191
   PubMed Web of Science ®Google Scholar
• Lacroix M, Leclercq G. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 2004; 83:249 - 89; http://dx.doi.org/10.1023/B:BREA.0000014042.54925.cc; PMID: 14758095
   PubMed Web of Science ®Google Scholar
• MacLeod RA, Dirks WG, Matsuo Y, Kaufmann M, Milch H, Drexler HG. Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int J Cancer 1999; 83:555 - 63; http://dx.doi.org/10.1002/(SICI)1097-0215(19991112)83:4<555::AID-IJC19>3.0.CO;2-2; PMID: 10508494
   PubMed Web of Science ®Google Scholar
• Borowsky AD. Choosing a mouse model: experimental biology in context--the utility and limitations of mouse models of breast cancer. Cold Spring Harb Perspect Biol 2011; 3:a009670; http://dx.doi.org/10.1101/cshperspect.a009670; PMID: 21646376
   PubMedGoogle Scholar
• Bargmann CI, Hung MC, Weinberg RA. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 1986; 319:226 - 30; http://dx.doi.org/10.1038/319226a0; PMID: 3945311
   PubMed Web of Science ®Google Scholar
• Kari FW, Weaver R, Neville MC. Active transport of nitrofurantoin across the mammary epithelium in vivo. J Pharmacol Exp Ther 1997; 280:664 - 8; PMID: 9023277
   PubMed Web of Science ®Google Scholar
• Monks J, Neville MC. Albumin transcytosis across the epithelium of the lactating mouse mammary gland. J Physiol 2004; 560:267 - 80; http://dx.doi.org/10.1113/jphysiol.2004.068403; PMID: 15297572
   PubMed Web of Science ®Google Scholar
• Nguyen DA, Parlow AF, Neville MC. Hormonal regulation of tight junction closure in the mouse mammary epithelium during the transition from pregnancy to lactation. J Endocrinol 2001; 170:347 - 56; http://dx.doi.org/10.1677/joe.0.1700347; PMID: 11479131
   PubMed Web of Science ®Google Scholar
• Ussing HH. Transport through biological membranes. Annu Rev Physiol 1953; 15:1 - 20; http://dx.doi.org/10.1146/annurev.ph.15.030153.000245; PMID: 13125285
   PubMedGoogle Scholar
• Lee SY, Palmer ML, Maniak PJ, Jang SH, Ryu PD, O’Grady SM. P2Y receptor regulation of sodium transport in human mammary epithelial cells. Am J Physiol Cell Physiol 2007; 293:C1472 - 80; http://dx.doi.org/10.1152/ajpcell.00068.2007; PMID: 17715387
   PubMedGoogle Scholar
• Quesnell RR, Han X, Schultz BD. Glucocorticoids stimulate ENaC upregulation in bovine mammary epithelium. Am J Physiol Cell Physiol 2007; 292:C1739 - 45; http://dx.doi.org/10.1152/ajpcell.00369.2006; PMID: 17251323
   PubMedGoogle Scholar
• Bisbee CA, Machen TE, Bern HA. Mouse mammary epithelial cells on floating collagen gels: transepithelial ion transport and effects of prolactin. Proc Natl Acad Sci U S A 1979; 76:536 - 40; http://dx.doi.org/10.1073/pnas.76.1.536; PMID: 284373
   PubMedGoogle Scholar
• Marshall AM, Pai VP, Sartor MA, Horseman ND. In vitro multipotent differentiation and barrier function of a human mammary epithelium. Cell Tissue Res 2009; 335:383 - 95; http://dx.doi.org/10.1007/s00441-008-0719-0; PMID: 19005683
   PubMedGoogle Scholar
• Incassati A, Chandramouli A, Eelkema R, Cowin P. Key signaling nodes in mammary gland development and cancer: β-catenin. Breast Cancer Res 2010; 12:213; http://dx.doi.org/10.1186/bcr2723; PMID: 21067528
   PubMed Web of Science ®Google Scholar
• Chu EY, Hens J, Andl T, Kairo A, Yamaguchi TP, Brisken C, Glick A, Wysolmerski JJ, Millar SE. Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis. Development 2004; 131:4819 - 29; http://dx.doi.org/10.1242/dev.01347; PMID: 15342465
   PubMed Web of Science ®Google Scholar
• Hens J, Dann P, Hiremath M, Pan TC, Chodosh L, Wysolmerski J. Analysis of gene expression in PTHrP-/- mammary buds supports a role for BMP signaling and MMP2 in the initiation of ductal morphogenesis. Dev Dyn 2009; 238:2713 - 24; http://dx.doi.org/10.1002/dvdy.22097; PMID: 19795511
   PubMed Web of Science ®Google Scholar
• Zeng YA, Nusse R. Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture. Cell Stem Cell 2010; 6:568 - 77; http://dx.doi.org/10.1016/j.stem.2010.03.020; PMID: 20569694
   PubMed Web of Science ®Google Scholar
• Weber-Hall SJ, Phippard DJ, Niemeyer CC, Dale TC. Developmental and hormonal regulation of Wnt gene expression in the mouse mammary gland. Differentiation 1994; 57:205 - 14; http://dx.doi.org/10.1046/j.1432-0436.1994.5730205.x; PMID: 7988795
   PubMed Web of Science ®Google Scholar
• Lane TF, Leder P. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice. Oncogene 1997; 15:2133 - 44; http://dx.doi.org/10.1038/sj.onc.1201593; PMID: 9393971
   PubMed Web of Science ®Google Scholar
• Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, Dey SK, McMahon JA, McMahon AP, Weinberg RA. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 2000; 14:650 - 4; PMID: 10733525
   PubMed Web of Science ®Google Scholar
• Linzell JL, Peaker M. Changes in colostrum composition and in the permeability of the mammary epithelium at about the time of parturition in the goat. J Physiol 1974; 243:129 - 51; PMID: 4449059
   PubMed Web of Science ®Google Scholar
• Linzell JL, Peaker M. The permeability of mammary ducts. J Physiol 1971; 216:701 - 16; PMID: 5105749
   PubMed Web of Science ®Google Scholar
• Berga SE. Electrical potentials and cell-to-cell dye movement in mouse mammary gland during lactation. Am J Physiol 1984; 247:C20 - 5; PMID: 6742181
   PubMedGoogle Scholar
• Peaker M. Mechanism of milk secretion: milk composition in relation to potential difference across the mammary epithelium. J Physiol 1977; 270:489 - 505; PMID: 903903
   PubMed Web of Science ®Google Scholar
• Nguyen DA, Neville MC. Tight junction regulation in the mammary gland. J Mammary Gland Biol Neoplasia 1998; 3:233 - 46; http://dx.doi.org/10.1023/A:1018707309361; PMID: 10819511
   PubMed Web of Science ®Google Scholar
• Neville M. Determinants of milk volume and composition. A. Lactogenesis in women: A cascade of events revealed by milk composition. In: Jensen R, ed. Handbook of Milk Composition. San Diego: Academic Press:87-98.
   Google Scholar
• Morgan G, Wooding FB. A freeze-fracture study of tight junction structure in sheep mammary gland epithelium during pregnancy and lactation. J Dairy Res 1982; 49:1 - 11; http://dx.doi.org/10.1017/S002202990002207X; PMID: 7076943
   PubMedGoogle Scholar
• Itoh M, Bissell MJ. The organization of tight junctions in epithelia: implications for mammary gland biology and breast tumorigenesis. J Mammary Gland Biol Neoplasia 2003; 8:449 - 62; http://dx.doi.org/10.1023/B:JOMG.0000017431.45314.07; PMID: 14985640
   PubMedGoogle Scholar
• Stelwagen K, van Espen DC, Verkerk GA, McFadden HA, Farr VC. Elevated plasma cortisol reduces permeability of mammary tight junctions in the lactating bovine mammary epithelium. J Endocrinol 1998; 159:173 - 8; http://dx.doi.org/10.1677/joe.0.1590173; PMID: 9795355
   PubMed Web of Science ®Google Scholar
• Stelwagen K, McFadden HA, Demmer J. Prolactin, alone or in combination with glucocorticoids, enhances tight junction formation and expression of the tight junction protein occludin in mammary cells. Mol Cell Endocrinol 1999; 156:55 - 61; http://dx.doi.org/10.1016/S0303-7207(99)00145-8; PMID: 10612423
   PubMed Web of Science ®Google Scholar
• Pai VP, Horseman ND. Biphasic regulation of mammary epithelial resistance by serotonin through activation of multiple pathways. J Biol Chem 2008; 283:30901 - 10; http://dx.doi.org/10.1074/jbc.M802476200; PMID: 18782769
   PubMed Web of Science ®Google Scholar
• Kalantaridou SN, Makrigiannakis A, Zoumakis E, Chrousos GP. Reproductive functions of corticotropin-releasing hormone. Research and potential clinical utility of antalarmins (CRH receptor type 1 antagonists). Am J Reprod Immunol 2004; 51:269 - 74; http://dx.doi.org/10.1111/j.1600-0897.2004.00155.x; PMID: 15212679
   PubMedGoogle Scholar
• Burke CW, Roulet F. Increased exposure of tissues to cortisol in late pregnancy. Br Med J 1970; 1:657 - 9; http://dx.doi.org/10.1136/bmj.1.5697.657; PMID: 5443967
   PubMed Web of Science ®Google Scholar
• Rubenstein NM, Chan JF, Kim JY, Hansen SH, Firestone GL. Rnd3/RhoE induces tight junction formation in mammary epithelial tumor cells. Exp Cell Res 2005; 305:74 - 82; http://dx.doi.org/10.1016/j.yexcr.2004.12.010; PMID: 15777789
   PubMedGoogle Scholar
• Zettl KS, Sjaastad MD, Riskin PM, Parry G, Machen TE, Firestone GL. Glucocorticoid-induced formation of tight junctions in mouse mammary epithelial cells in vitro. Proc Natl Acad Sci U S A 1992; 89:9069 - 73; http://dx.doi.org/10.1073/pnas.89.19.9069; PMID: 1409603
   PubMed Web of Science ®Google Scholar
• Rubenstein NM, Guan Y, Woo PL, Firestone GL. Glucocorticoid down-regulation of RhoA is required for the steroid-induced organization of the junctional complex and tight junction formation in rat mammary epithelial tumor cells. J Biol Chem 2003; 278:10353 - 60; http://dx.doi.org/10.1074/jbc.M213121200; PMID: 12525486
   PubMedGoogle Scholar
• Failor KL, Desyatnikov Y, Finger LA, Firestone GL. Glucocorticoid-induced degradation of glycogen synthase kinase-3 protein is triggered by serum- and glucocorticoid-induced protein kinase and Akt signaling and controls beta-catenin dynamics and tight junction formation in mammary epithelial tumor cells. Mol Endocrinol 2007; 21:2403 - 15; http://dx.doi.org/10.1210/me.2007-0143; PMID: 17595317
   PubMed Web of Science ®Google Scholar
• Feng Z, Marti A, Jehn B, Altermatt HJ, Chicaiza G, Jaggi R. Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland. J Cell Biol 1995; 131:1095 - 103; http://dx.doi.org/10.1083/jcb.131.4.1095; PMID: 7490285
   PubMed Web of Science ®Google Scholar
• Linzell JL, Peaker M, Taylor JC. The effects of prolactin and oxytocin on milk secretion and on the permeability of the mammary epithelium in the rabbit. J Physiol 1975; 253:547 - 63; PMID: 1214226
   PubMed Web of Science ®Google Scholar
• Flint DJ, Gardner M. Evidence that growth hormone stimulates milk synthesis by direct action on the mammary gland and that prolactin exerts effects on milk secretion by maintenance of mammary deoxyribonucleic acid content and tight junction status. Endocrinology 1994; 135:1119 - 24; http://dx.doi.org/10.1210/en.135.3.1119; PMID: 8070355
   PubMedGoogle Scholar
• Sheffield L, Kotolski L. Prolactin inhibits programmed cell death during mammary gland involution. FASEB J 1992; 6:A1184
   Web of Science ®Google Scholar
• Lin Y, Xia L, Turner JD, Zhao X. Morphologic observation of neutrophil diapedesis across bovine mammary gland epithelium in vitro. Am J Vet Res 1995; 56:203 - 7; PMID: 7717587
   PubMed Web of Science ®Google Scholar
• Matsuda M, Imaoka T, Vomachka AJ, Gudelsky GA, Hou Z, Mistry M, Bailey JP, Nieport KM, Walther DJ, Bader M, et al. Serotonin regulates mammary gland development via an autocrine-paracrine loop. Dev Cell 2004; 6:193 - 203; http://dx.doi.org/10.1016/S1534-5807(04)00022-X; PMID: 14960274
   PubMed Web of Science ®Google Scholar
• Stull MA, Pai V, Vomachka AJ, Marshall AM, Jacob GA, Horseman ND. Mammary gland homeostasis employs serotonergic regulation of epithelial tight junctions. Proc Natl Acad Sci U S A 2007; 104:16708 - 13; http://dx.doi.org/10.1073/pnas.0708136104; PMID: 17940054
   PubMed Web of Science ®Google Scholar
• Balsa JA, Sánchez-Franco F, Pazos F, Lara JI, Lorenzo MJ, Maldonado G, Cacicedo L. Direct action of serotonin on prolactin, growth hormone, corticotropin and luteinizing hormone release in cocultures of anterior and posterior pituitary lobes: autocrine and/or paracrine action of vasoactive intestinal peptide. Neuroendocrinology 1998; 68:326 - 33; http://dx.doi.org/10.1159/000054381; PMID: 9822800
   PubMed Web of Science ®Google Scholar
• Linzell JL, Peaker M. Day-to-day variations in milk composition in the goat and cow as a guide to the detection of subclinical mastitis. Br Vet J 1972; 128:284 - 95; PMID: 4672325
   PubMedGoogle Scholar
• Juric M, Xiao F, Amasheh S, May O, Wahl K, Bantel H, Manns MP, Seidler U, Bachmann O. Increased epithelial permeability is the primary cause for bicarbonate loss in inflamed murine colon. Inflamm Bowel Dis 2013; 19:904 - 11; http://dx.doi.org/10.1097/MIB.0b013e3182813322; PMID: 23502355
   PubMedGoogle Scholar
• Cui W, Li LX, Sun CM, Wen Y, Zhou Y, Dong YL, Liu P. Tumor necrosis factor alpha increases epithelial barrier permeability by disrupting tight junctions in Caco-2 cells. Braz J Med Biol Res 2010; 43:330 - 7; http://dx.doi.org/10.1590/S0100-879X2010007500020; PMID: 20445948
   PubMed Web of Science ®Google Scholar
• Zhang Q, Fisher K. Tight junction-related barrier contributes to the electrophysiological asymmetry across vocal fold epithelium. PLoS One 2012; 7:e34017; http://dx.doi.org/10.1371/journal.pone.0034017; PMID: 22442739
   PubMedGoogle Scholar
• Flynn AN, Itani OA, Moninger TO, Welsh MJ. Acute regulation of tight junction ion selectivity in human airway epithelia. Proc Natl Acad Sci U S A 2009; 106:3591 - 6; http://dx.doi.org/10.1073/pnas.0813393106; PMID: 19208806
   PubMed Web of Science ®Google Scholar
• Stepánková R, Kofronová O, Tucková L, Kozáková H, Cebra JJ, Tlaskalová- Hogenová H. Experimentally induced gluten enteropathy and protective effect of epidermal growth factor in artificially fed neonatal rats. J Pediatr Gastroenterol Nutr 2003; 36:96 - 104; http://dx.doi.org/10.1097/00005176-200301000-00018; PMID: 12500003
   PubMedGoogle Scholar
• Cenac N, Chin AC, Garcia-Villar R, Salvador-Cartier C, Ferrier L, Vergnolle N, Buret AG, Fioramonti J, Bueno L. PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and -independent pathways. J Physiol 2004; 558:913 - 25; http://dx.doi.org/10.1113/jphysiol.2004.061721; PMID: 15194744
   PubMed Web of Science ®Google Scholar
• Lemmers C, Michel D, Lane-Guermonprez L, Delgrossi MH, Médina E, Arsanto JP, Le Bivic A. CRB3 binds directly to Par6 and regulates the morphogenesis of the tight junctions in mammalian epithelial cells. Mol Biol Cell 2004; 15:1324 - 33; http://dx.doi.org/10.1091/mbc.E03-04-0235; PMID: 14718572
   PubMed Web of Science ®Google Scholar
• Fogg VC, Liu CJ, Margolis B. Multiple regions of Crumbs3 are required for tight junction formation in MCF10A cells. J Cell Sci 2005; 118:2859 - 69; http://dx.doi.org/10.1242/jcs.02412; PMID: 15976445
   PubMedGoogle Scholar
• Michel D, Arsanto JP, Massey-Harroche D, Béclin C, Wijnholds J, Le Bivic A. PATJ connects and stabilizes apical and lateral components of tight junctions in human intestinal cells. J Cell Sci 2005; 118:4049 - 57; http://dx.doi.org/10.1242/jcs.02528; PMID: 16129888
   PubMed Web of Science ®Google Scholar
• Hurd TW, Gao L, Roh MH, Macara IG, Margolis B. Direct interaction of two polarity complexes implicated in epithelial tight junction assembly. Nat Cell Biol 2003; 5:137 - 42; http://dx.doi.org/10.1038/ncb923; PMID: 12545177
   PubMed Web of Science ®Google Scholar
• Roh MH, Liu CJ, Laurinec S, Margolis B. The carboxyl terminus of zona occludens-3 binds and recruits a mammalian homologue of discs lost to tight junctions. J Biol Chem 2002; 277:27501 - 9; http://dx.doi.org/10.1074/jbc.M201177200; PMID: 12021270
   PubMed Web of Science ®Google Scholar
• Ebnet K, Suzuki A, Horikoshi Y, Hirose T, Meyer Zu Brickwedde MK, Ohno S, Vestweber D. The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM). EMBO J 2001; 20:3738 - 48; http://dx.doi.org/10.1093/emboj/20.14.3738; PMID: 11447115
   PubMed Web of Science ®Google Scholar
• Feng W, Wu H, Chan LN, Zhang M. Par-3-mediated junctional localization of the lipid phosphatase PTEN is required for cell polarity establishment. J Biol Chem 2008; 283:23440 - 9; http://dx.doi.org/10.1074/jbc.M802482200; PMID: 18550519
   PubMed Web of Science ®Google Scholar
• Chen X, Macara IG. Par-3 controls tight junction assembly through the Rac exchange factor Tiam1. Nat Cell Biol 2005; 7:262 - 9; http://dx.doi.org/10.1038/ncb1226; PMID: 15723052
   PubMed Web of Science ®Google Scholar
• Martin-Belmonte F, Gassama A, Datta A, Yu W, Rescher U, Gerke V, Mostov K. PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell 2007; 128:383 - 97; http://dx.doi.org/10.1016/j.cell.2006.11.051; PMID: 17254974
   PubMed Web of Science ®Google Scholar
• Nagasaka K, Nakagawa S, Yano T, Takizawa S, Matsumoto Y, Tsuruga T, Nakagawa K, Minaguchi T, Oda K, Hiraike-Wada O, et al. Human homolog of Drosophila tumor suppressor Scribble negatively regulates cell-cycle progression from G1 to S phase by localizing at the basolateral membrane in epithelial cells. Cancer Sci 2006; 97:1217 - 25; http://dx.doi.org/10.1111/j.1349-7006.2006.00315.x; PMID: 16965391
   PubMed Web of Science ®Google Scholar
• Albertson R, Chabu C, Sheehan A, Doe CQ. Scribble protein domain mapping reveals a multistep localization mechanism and domains necessary for establishing cortical polarity. J Cell Sci 2004; 117:6061 - 70; http://dx.doi.org/10.1242/jcs.01525; PMID: 15536119
   PubMed Web of Science ®Google Scholar
• Ivanov AI, Young C, Den Beste K, Capaldo CT, Humbert PO, Brennwald P, Parkos CA, Nusrat A. Tumor suppressor scribble regulates assembly of tight junctions in the intestinal epithelium. Am J Pathol 2010; 176:134 - 45; http://dx.doi.org/10.2353/ajpath.2010.090220; PMID: 19959811
   PubMed Web of Science ®Google Scholar
• Navarro C, Nola S, Audebert S, Santoni MJ, Arsanto JP, Ginestier C, Marchetto S, Jacquemier J, Isnardon D, Le Bivic A, et al. Junctional recruitment of mammalian Scribble relies on E-cadherin engagement. Oncogene 2005; 24:4330 - 9; http://dx.doi.org/10.1038/sj.onc.1208632; PMID: 15806148
   PubMed Web of Science ®Google Scholar
• Bilder D, Perrimon N. Localization of apical epithelial determinants by the basolateral PDZ protein Scribble. Nature 2000; 403:676 - 80; http://dx.doi.org/10.1038/35001108; PMID: 10688207
   PubMed Web of Science ®Google Scholar
• Qin Y, Capaldo C, Gumbiner BM, Macara IG. The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. J Cell Biol 2005; 171:1061 - 71; http://dx.doi.org/10.1083/jcb.200506094; PMID: 16344308
   PubMed Web of Science ®Google Scholar
• Martin-Belmonte F, Perez-Moreno M. Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 2012; 12:23 - 38; PMID: 22169974
   PubMed Web of Science ®Google Scholar
• Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M, Mikulits W, Brabletz T, Strand D, Obrist P, et al. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007; 26:6979 - 88; http://dx.doi.org/10.1038/sj.onc.1210508; PMID: 17486063
   PubMed Web of Science ®Google Scholar
• Nolan ME, Aranda V, Lee S, Lakshmi B, Basu S, Allred DC, Muthuswamy SK. The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer. Cancer Res 2008; 68:8201 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-07-6567; PMID: 18922891
   PubMed Web of Science ®Google Scholar
• Aranda V, Haire T, Nolan ME, Calarco JP, Rosenberg AZ, Fawcett JP, Pawson T, Muthuswamy SK. Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. Nat Cell Biol 2006; 8:1235 - 45; http://dx.doi.org/10.1038/ncb1485; PMID: 17060907
   PubMed Web of Science ®Google Scholar
• Zhan L, Rosenberg A, Bergami KC, Yu M, Xuan Z, Jaffe AB, Allred C, Muthuswamy SK. Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell 2008; 135:865 - 78; http://dx.doi.org/10.1016/j.cell.2008.09.045; PMID: 19041750
   PubMed Web of Science ®Google Scholar
• Osanai M, Murata M, Nishikiori N, Chiba H, Kojima T, Sawada N. Occludin-mediated premature senescence is a fail-safe mechanism against tumorigenesis in breast carcinoma cells. Cancer Sci 2007; 98:1027 - 34; http://dx.doi.org/10.1111/j.1349-7006.2007.00494.x; PMID: 17459053
   PubMedGoogle Scholar
• Hoover KB, Liao SY, Bryant PJ. Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity. Am J Pathol 1998; 153:1767 - 73; http://dx.doi.org/10.1016/S0002-9440(10)65691-X; PMID: 9846967
   PubMedGoogle Scholar
• Mandell KJ, Babbin BA, Nusrat A, Parkos CA. Junctional adhesion molecule 1 regulates epithelial cell morphology through effects on beta1 integrins and Rap1 activity. J Biol Chem 2005; 280:11665 - 74; http://dx.doi.org/10.1074/jbc.M412650200; PMID: 15677455
   PubMed Web of Science ®Google Scholar
• Naik MU, Naik TU, Suckow AT, Duncan MK, Naik UP. Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion. Cancer Res 2008; 68:2194 - 203; http://dx.doi.org/10.1158/0008-5472.CAN-07-3057; PMID: 18381425
   PubMed Web of Science ®Google Scholar
• McSherry EA, McGee SF, Jirstrom K, Doyle EM, Brennan DJ, Landberg G, Dervan PA, Hopkins AM, Gallagher WM. JAM-A expression positively correlates with poor prognosis in breast cancer patients. Int J Cancer 2009; 125:1343 - 51; http://dx.doi.org/10.1002/ijc.24498; PMID: 19533747
   PubMed Web of Science ®Google Scholar
• Brennan K, McSherry EA, Hudson L, Kay EW, Hill AD, Young LS, et al. Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling. Oncogene 2012; PMID: 22751120
   PubMed Web of Science ®Google Scholar
• Götte M, Mohr C, Koo CY, Stock C, Vaske AK, Viola M, Ibrahim SA, Peddibhotla S, Teng YH, Low JY, et al. miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness. Oncogene 2010; 29:6569 - 80; http://dx.doi.org/10.1038/onc.2010.386; PMID: 20818426
   PubMed Web of Science ®Google Scholar
• Murakami M, Giampietro C, Giannotta M, Corada M, Torselli I, Orsenigo F, Cocito A, d’Ario G, Mazzarol G, Confalonieri S, et al. Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression. PLoS One 2011; 6:e21242; http://dx.doi.org/10.1371/journal.pone.0021242; PMID: 21695058
   PubMedGoogle Scholar
• Christofori G. New signals from the invasive front. Nature 2006; 441:444 - 50; http://dx.doi.org/10.1038/nature04872; PMID: 16724056
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139:871 - 90; http://dx.doi.org/10.1016/j.cell.2009.11.007; PMID: 19945376
   PubMed Web of Science ®Google Scholar
• Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999; 147:631 - 44; http://dx.doi.org/10.1083/jcb.147.3.631; PMID: 10545506
   PubMed Web of Science ®Google Scholar
• Hashizume R, Koizumi H, Ihara A, Ohta T, Uchikoshi T. Expression of beta-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and alpha-catenin. Histopathology 1996; 29:139 - 46; http://dx.doi.org/10.1046/j.1365-2559.1996.d01-499.x; PMID: 8872147
   PubMedGoogle Scholar
• Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, Millis RR. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 1993; 169:245 - 50; http://dx.doi.org/10.1002/path.1711690211; PMID: 8383197
   PubMed Web of Science ®Google Scholar
• Moll R, Mitze M, Frixen UH, Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993; 143:1731 - 42; PMID: 8256859
   PubMed Web of Science ®Google Scholar
• Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter Haar NT, van Roy F, Cornelisse CJ, Peterse JL, van de Vijver MJ. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997; 76:1131 - 3; http://dx.doi.org/10.1038/bjc.1997.523; PMID: 9365159
   PubMed Web of Science ®Google Scholar
• De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen AM. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997; 183:404 - 11; http://dx.doi.org/10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9; PMID: 9496256
   PubMed Web of Science ®Google Scholar
• Berx G, Becker KF, Höfler H, van Roy F. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998; 12:226 - 37; http://dx.doi.org/10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; PMID: 9744472
   PubMed Web of Science ®Google Scholar
• Adachi Y, Takeuchi T, Nagayama T, Ohtsuki Y, Furihata M. Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer. FEBS Lett 2009; 583:430 - 6; http://dx.doi.org/10.1016/j.febslet.2008.12.042; PMID: 19116147
   PubMed Web of Science ®Google Scholar
• Schmalhofer O, Brabletz S, Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 2009; 28:151 - 66; http://dx.doi.org/10.1007/s10555-008-9179-y; PMID: 19153669
   PubMed Web of Science ®Google Scholar
• Strathdee G. Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin Cancer Biol 2002; 12:373 - 9; http://dx.doi.org/10.1016/S1044-579X(02)00057-3; PMID: 12191636
   PubMed Web of Science ®Google Scholar
• Kang Y, Massagué J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004; 118:277 - 9; http://dx.doi.org/10.1016/j.cell.2004.07.011; PMID: 15294153
   PubMed Web of Science ®Google Scholar
• De Craene B, van Roy F, Berx G. Unraveling signalling cascades for the Snail family of transcription factors. Cell Signal 2005; 17:535 - 47; http://dx.doi.org/10.1016/j.cellsig.2004.10.011; PMID: 15683729
   PubMed Web of Science ®Google Scholar
• Peinado H, Ballestar E, Esteller M, Cano A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 2004; 24:306 - 19; http://dx.doi.org/10.1128/MCB.24.1.306-319.2004; PMID: 14673164
   PubMed Web of Science ®Google Scholar
• Peinado H, Del Carmen Iglesias-de la Cruz M, Olmeda D, Csiszar K, Fong KS, Vega S, Nieto MA, Cano A, Portillo F. A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J 2005; 24:3446 - 58; http://dx.doi.org/10.1038/sj.emboj.7600781; PMID: 16096638
   PubMed Web of Science ®Google Scholar
• Howe LR, Watanabe O, Leonard J, Brown AM. Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res 2003; 63:1906 - 13; PMID: 12702582
   PubMed Web of Science ®Google Scholar
• Saxena M, Stephens MA, Pathak H, Rangarajan A. Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters. Cell Death Dis 2011; 2:e179; http://dx.doi.org/10.1038/cddis.2011.61; PMID: 21734725
   PubMed Web of Science ®Google Scholar
• Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 2007; 67:1979 - 87; http://dx.doi.org/10.1158/0008-5472.CAN-06-1479; PMID: 17332325
   PubMed Web of Science ®Google Scholar
• Suyama K, Shapiro I, Guttman M, Hazan RB. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2002; 2:301 - 14; http://dx.doi.org/10.1016/S1535-6108(02)00150-2; PMID: 12398894
   PubMed Web of Science ®Google Scholar
• Lin HJ, Zuo T, Chao JR, Peng Z, Asamoto LK, Yamashita SS, Huang TH. Seed in soil, with an epigenetic view. Biochim Biophys Acta 2009; 1790:920 - 4; http://dx.doi.org/10.1016/j.bbagen.2008.12.004; PMID: 19162126
   PubMedGoogle Scholar
• Fedor-Chaiken M, Hein PW, Stewart JC, Brackenbury R, Kinch MS. E-cadherin binding modulates EGF receptor activation. Cell Commun Adhes 2003; 10:105 - 18; PMID: 14681060
   PubMed Web of Science ®Google Scholar
• Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG, Hung MC. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci U S A 2000; 97:4262 - 6; http://dx.doi.org/10.1073/pnas.060025397; PMID: 10759547
   PubMed Web of Science ®Google Scholar
• Ozaki S, Ikeda S, Ishizaki Y, Kurihara T, Tokumoto N, Iseki M, Arihiro K, Kataoka T, Okajima M, Asahara T. Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer. Oncol Rep 2005; 14:1437 - 43; PMID: 16273236
   PubMed Web of Science ®Google Scholar
• Prasad CP, Mirza S, Sharma G, Prashad R, DattaGupta S, Rath G, Ralhan R. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast. Life Sci 2008; 83:318 - 25; http://dx.doi.org/10.1016/j.lfs.2008.06.019; PMID: 18662704
   PubMedGoogle Scholar
• Karayiannakis AJ, Nakopoulou L, Gakiopoulou H, Keramopoulos A, Davaris PS, Pignatelli M. Expression patterns of beta-catenin in in situ and invasive breast cancer. Eur J Surg Oncol 2001; 27:31 - 6; http://dx.doi.org/10.1053/ejso.1999.1017; PMID: 11237489
   PubMedGoogle Scholar
• Nagahata T, Shimada T, Harada A, Nagai H, Onda M, Yokoyama S, Shiba T, Jin E, Kawanami O, Emi M. Amplification, up-regulation and over-expression of DVL-1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers. Cancer Sci 2003; 94:515 - 8; http://dx.doi.org/10.1111/j.1349-7006.2003.tb01475.x; PMID: 12824876
   PubMed Web of Science ®Google Scholar
• Liu CC, Prior J, Piwnica-Worms D, Bu G. LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy. Proc Natl Acad Sci U S A 2010; 107:5136 - 41; http://dx.doi.org/10.1073/pnas.0911220107; PMID: 20194742
   PubMedGoogle Scholar
• Björklund P, Svedlund J, Olsson AK, Akerström G, Westin G. The internally truncated LRP5 receptor presents a therapeutic target in breast cancer. PLoS One 2009; 4:e4243; http://dx.doi.org/10.1371/journal.pone.0004243; PMID: 19158955
   PubMedGoogle Scholar
• Jönsson M, Dejmek J, Bendahl PO, Andersson T. Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res 2002; 62:409 - 16; PMID: 11809689
   PubMed Web of Science ®Google Scholar
• Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB, Iglehart JD. NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci U S A 2004; 101:10137 - 42; http://dx.doi.org/10.1073/pnas.0403621101; PMID: 15220474
   PubMed Web of Science ®Google Scholar
• Ryo A, Nakamura M, Wulf G, Liou YC, Lu KP. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol 2001; 3:793 - 801; http://dx.doi.org/10.1038/ncb0901-793; PMID: 11533658
   PubMed Web of Science ®Google Scholar
• Wulf GM, Ryo A, Wulf GG, Lee SW, Niu T, Petkova V, Lu KP. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J 2001; 20:3459 - 72; http://dx.doi.org/10.1093/emboj/20.13.3459; PMID: 11432833
   PubMed Web of Science ®Google Scholar
• Zhao H, Cui Y, Dupont J, Sun H, Hennighausen L, Yakar S. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis. Cancer Res 2005; 65:6864 - 73; http://dx.doi.org/10.1158/0008-5472.CAN-05-0181; PMID: 16061670
   PubMedGoogle Scholar
• Depowski PL, Rosenthal SI, Ross JS. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer. Mod Pathol 2001; 14:672 - 6; http://dx.doi.org/10.1038/modpathol.3880371; PMID: 11454999
   PubMed Web of Science ®Google Scholar
• Knudsen KA, Lin CY, Johnson KR, Wheelock MJ, Keshgegian AA, Soler AP. Lack of correlation between serum levels of E- and P-cadherin fragments and the presence of breast cancer. Hum Pathol 2000; 31:961 - 5; http://dx.doi.org/10.1053/hupa.2000.9074; PMID: 10987257
   PubMedGoogle Scholar
• Turashvili G, McKinney SE, Goktepe O, Leung SC, Huntsman DG, Gelmon KA, Los G, Rejto PA, Aparicio SA. P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer. Mod Pathol 2011; 24:64 - 81; http://dx.doi.org/10.1038/modpathol.2010.189; PMID: 20852590
   PubMed Web of Science ®Google Scholar
• Sousa B, Paredes J, Milanezi F, Lopes N, Martins D, Dufloth R, Vieira D, Albergaria A, Veronese L, Carneiro V, et al. P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study. Histol Histopathol 2010; 25:963 - 74; PMID: 20552547
   PubMed Web of Science ®Google Scholar
• Albergaria A, Ribeiro AS, Vieira AF, Sousa B, Nobre AR, Seruca R, Schmitt F, Paredes J. P-cadherin role in normal breast development and cancer. Int J Dev Biol 2011; 55:811 - 22; http://dx.doi.org/10.1387/ijdb.113382aa; PMID: 22161837
   PubMed Web of Science ®Google Scholar
• Lou Y, Preobrazhenska O, auf dem Keller U, Sutcliffe M, Barclay L, McDonald PC, Roskelley C, Overall CM, Dedhar S. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis. Dev Dyn 2008; 237:2755 - 68; http://dx.doi.org/10.1002/dvdy.21658; PMID: 18773493
   PubMedGoogle Scholar
• Ben Hamida A, Labidi IS, Mrad K, Charafe-Jauffret E, Ben Arab S, Esterni B, Xerri L, Viens P, Bertucci F, Birnbaum D, et al. Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherin. BMC Cancer 2008; 8:28; http://dx.doi.org/10.1186/1471-2407-8-28; PMID: 18230143
   PubMedGoogle Scholar
• Davis MA, Reynolds AB. Blocked acinar development, E-cadherin reduction, and intraepithelial neoplasia upon ablation of p120-catenin in the mouse salivary gland. Dev Cell 2006; 10:21 - 31; http://dx.doi.org/10.1016/j.devcel.2005.12.004; PMID: 16399075
   PubMed Web of Science ®Google Scholar
• Stairs DB, Bayne LJ, Rhoades B, Vega ME, Waldron TJ, Kalabis J, Klein-Szanto A, Lee JS, Katz JP, Diehl JA, et al. Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. Cancer Cell 2011; 19:470 - 83; http://dx.doi.org/10.1016/j.ccr.2011.02.007; PMID: 21481789
   PubMed Web of Science ®Google Scholar
• van Amerongen R, Berns A. Knockout mouse models to study Wnt signal transduction. Trends Genet 2006; 22:678 - 89; http://dx.doi.org/10.1016/j.tig.2006.10.001; PMID: 17045694
   PubMedGoogle Scholar
• Wolf K, Friedl P. Molecular mechanisms of cancer cell invasion and plasticity. Br J Dermatol 2006; 154:Suppl 1 11 - 5; http://dx.doi.org/10.1111/j.1365-2133.2006.07231.x; PMID: 16712711
   PubMedGoogle Scholar
• Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Bröcker EB, Friedl P. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 2003; 160:267 - 77; http://dx.doi.org/10.1083/jcb.200209006; PMID: 12527751
   PubMed Web of Science ®Google Scholar
• Dumin JA, Dickeson SK, Stricker TP, Bhattacharyya-Pakrasi M, Roby JD, Santoro SA, Parks WC. Pro-collagenase-1 (matrix metalloproteinase-1) binds the alpha(2)beta(1) integrin upon release from keratinocytes migrating on type I collagen. J Biol Chem 2001; 276:29368 - 74; http://dx.doi.org/10.1074/jbc.M104179200; PMID: 11359786
   PubMed Web of Science ®Google Scholar
• Webb DJ, Parsons JT, Horwitz AF. Adhesion assembly, disassembly and turnover in migrating cells -- over and over and over again. Nat Cell Biol 2002; 4:E97 - 100; http://dx.doi.org/10.1038/ncb0402-e97; PMID: 11944043
   PubMed Web of Science ®Google Scholar
• Friedl P, Noble PB, Walton PA, Laird DW, Chauvin PJ, Tabah RJ, Black M, Zänker KS. Migration of coordinated cell clusters in mesenchymal and epithelial cancer explants in vitro. Cancer Res 1995; 55:4557 - 60; PMID: 7553628
   PubMed Web of Science ®Google Scholar
• Davies M, Robinson M, Smith E, Huntley S, Prime S, Paterson I. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem 2005; 95:918 - 31; http://dx.doi.org/10.1002/jcb.20458; PMID: 15861394
   PubMed Web of Science ®Google Scholar
• Mandell KJ, Parkos CA. The JAM family of proteins. Adv Drug Deliv Rev 2005; 57:857 - 67; http://dx.doi.org/10.1016/j.addr.2005.01.005; PMID: 15820556
   PubMed Web of Science ®Google Scholar
• McSherry EA, Brennan K, Hudson L, Hill AD, Hopkins AM. Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase. Breast Cancer Res 2011; 13:R31; http://dx.doi.org/10.1186/bcr2853; PMID: 21429211
   PubMed Web of Science ®Google Scholar
• Furuse M, Tsukita S. Claudins in occluding junctions of humans and flies. Trends Cell Biol 2006; 16:181 - 8; http://dx.doi.org/10.1016/j.tcb.2006.02.006; PMID: 16537104
   PubMed Web of Science ®Google Scholar
• Anderson JM, Van Itallie CM, Fanning AS. Setting up a selective barrier at the apical junction complex. Curr Opin Cell Biol 2004; 16:140 - 5; http://dx.doi.org/10.1016/j.ceb.2004.01.005; PMID: 15196556
   PubMed Web of Science ®Google Scholar
• Webb PG, Spillman MA, Baumgartner HK. Claudins play a role in normal and tumor cell motility. BMC Cell Biol 2013; 14:19; http://dx.doi.org/10.1186/1471-2121-14-19; PMID: 23521713
   PubMed Web of Science ®Google Scholar
• Lanigan F, McKiernan E, Brennan DJ, Hegarty S, Millikan RC, McBryan J, Jirstrom K, Landberg G, Martin F, Duffy MJ, et al. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer. Int J Cancer 2009; 124:2088 - 97; http://dx.doi.org/10.1002/ijc.24159; PMID: 19142967
   PubMed Web of Science ®Google Scholar
• Escudero-Esparza A, Jiang WG, Martin TA. Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways. J Exp Clin Cancer Res 2012; 31:43; http://dx.doi.org/10.1186/1756-9966-31-43; PMID: 22559840
   PubMedGoogle Scholar
• Wu Q, Liu Y, Ren Y, Xu X, Yu L, Li Y, Quan C. Tight junction protein, claudin-6, downregulates the malignant phenotype of breast carcinoma. Eur J Cancer Prev 2010; 19:186 - 94; http://dx.doi.org/10.1097/CEJ.0b013e328337210e; PMID: 20215972
   PubMedGoogle Scholar
• Martin TA, Harrison GM, Watkins G, Jiang WG. Claudin-16 reduces the aggressive behavior of human breast cancer cells. J Cell Biochem 2008; 105:41 - 52; http://dx.doi.org/10.1002/jcb.21797; PMID: 18442037
   PubMedGoogle Scholar
• Osanai M, Murata M, Chiba H, Kojima T, Sawada N. Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells. Cancer Sci 2007; 98:1557 - 62; http://dx.doi.org/10.1111/j.1349-7006.2007.00569.x; PMID: 17645772
   PubMedGoogle Scholar
• Tokés AM, Kulka J, Paku S, Szik A, Páska C, Novák PK, Szilák L, Kiss A, Bögi K, Schaff Z. Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 2005; 7:R296 - 305; http://dx.doi.org/10.1186/bcr983; PMID: 15743508
   PubMed Web of Science ®Google Scholar
• Blanchard AA, Skliris GP, Watson PH, Murphy LC, Penner C, Tomes L, Young TL, Leygue E, Myal Y. Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype. Virchows Arch 2009; 454:647 - 56; http://dx.doi.org/10.1007/s00428-009-0770-6; PMID: 19387682
   PubMed Web of Science ®Google Scholar
• Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007; 8:R76; http://dx.doi.org/10.1186/gb-2007-8-5-r76; PMID: 17493263
   PubMed Web of Science ®Google Scholar
• Ladwein M, Pape UF, Schmidt DS, Schnölzer M, Fiedler S, Langbein L, Franke WW, Moldenhauer G, Zöller M. The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7. Exp Cell Res 2005; 309:345 - 57; http://dx.doi.org/10.1016/j.yexcr.2005.06.013; PMID: 16054130
   PubMed Web of Science ®Google Scholar
• Lei Z, Maeda T, Tamura A, Nakamura T, Yamazaki Y, Shiratori H, Yashiro K, Tsukita S, Hamada H. EpCAM contributes to formation of functional tight junction in the intestinal epithelium by recruiting claudin proteins. Dev Biol 2012; 371:136 - 45; http://dx.doi.org/10.1016/j.ydbio.2012.07.005; PMID: 22819673
   PubMed Web of Science ®Google Scholar
• Wu CJ, Mannan P, Lu M, Udey MC. Epithelial cell adhesion molecule (EpCAM) regulates claudin dynamics and tight junctions. J Biol Chem 2013; 288:12253 - 68; http://dx.doi.org/10.1074/jbc.M113.457499; PMID: 23486470
   PubMed Web of Science ®Google Scholar
• Wheelock MJ, Soler AP, Knudsen KA. Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia 2001; 6:275 - 85; http://dx.doi.org/10.1023/A:1011319507155; PMID: 11547897
   PubMed Web of Science ®Google Scholar
• Sarrió D, Palacios J, Hergueta-Redondo M, Gómez-López G, Cano A, Moreno-Bueno G. Functional characterization of E- and P-cadherin in invasive breast cancer cells. BMC Cancer 2009; 9:74; http://dx.doi.org/10.1186/1471-2407-9-74; PMID: 19257890
   PubMedGoogle Scholar
• Heyder C, Gloria-Maercker E, Entschladen F, Hatzmann W, Niggemann B, Zänker KS, Dittmar T. Realtime visualization of tumor cell/endothelial cell interactions during transmigration across the endothelial barrier. J Cancer Res Clin Oncol 2002; 128:533 - 8; http://dx.doi.org/10.1007/s00432-002-0377-7; PMID: 12384796
   PubMedGoogle Scholar
• Brandt B, Heyder C, Gloria-Maercker E, Hatzmann W, Rötger A, Kemming D, Zänker KS, Entschladen F, Dittmar T. 3D-extravasation model -- selection of highly motile and metastatic cancer cells. Semin Cancer Biol 2005; 15:387 - 95; http://dx.doi.org/10.1016/j.semcancer.2005.06.006; PMID: 16054390
   PubMedGoogle Scholar
• Uchide K, Sakon M, Ariyoshi H, Nakamori S, Tokunaga M, Monden M. Cancer cells cause vascular endothelial cell (vEC) retraction via 12(S)HETE secretion; the possible role of cancer cell derived microparticle. Ann Surg Oncol 2007; 14:862 - 8; http://dx.doi.org/10.1245/s10434-006-9225-3; PMID: 17103063
   PubMedGoogle Scholar
• Kebers F, Lewalle JM, Desreux J, Munaut C, Devy L, Foidart JM, Noël A. Induction of endothelial cell apoptosis by solid tumor cells. Exp Cell Res 1998; 240:197 - 205; http://dx.doi.org/10.1006/excr.1998.3935; PMID: 9596992
   PubMedGoogle Scholar
• Qi J, Chen N, Wang J, Siu CH. Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. Mol Biol Cell 2005; 16:4386 - 97; http://dx.doi.org/10.1091/mbc.E05-03-0186; PMID: 15987741
   PubMed Web of Science ®Google Scholar
• Strell C, Lang K, Niggemann B, Zaenker KS, Entschladen F. Surface molecules regulating rolling and adhesion to endothelium of neutrophil granulocytes and MDA-MB-468 breast carcinoma cells and their interaction. Cell Mol Life Sci 2007; 64:3306 - 16; http://dx.doi.org/10.1007/s00018-007-7402-6; PMID: 17994288
   PubMed Web of Science ®Google Scholar
• Tabariès S, Dupuy F, Dong Z, Monast A, Annis MG, Spicer J, Ferri LE, Omeroglu A, Basik M, Amir E, et al. Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytes. Mol Cell Biol 2012; 32:2979 - 91; http://dx.doi.org/10.1128/MCB.00299-12; PMID: 22645303
   PubMed Web of Science ®Google Scholar
• Tabariès S, Dong Z, Annis MG, Omeroglu A, Pepin F, Ouellet V, Russo C, Hassanain M, Metrakos P, Diaz Z, et al. Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Oncogene 2011; 30:1318 - 28; http://dx.doi.org/10.1038/onc.2010.518; PMID: 21076473
   PubMed Web of Science ®Google Scholar
• Erin N, Wang N, Xin P, Bui V, Weisz J, Barkan GA, Zhao W, Shearer D, Clawson GA. Altered gene expression in breast cancer liver metastases. Int J Cancer 2009; 124:1503 - 16; http://dx.doi.org/10.1002/ijc.24131; PMID: 19117052
   PubMedGoogle Scholar
• Tsukada Y, Fouad A, Pickren J, Lane W. Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 1983; 52:2359 - 54; http://dx.doi.org/10.1002/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B; PMID: 6640508
   PubMedGoogle Scholar
• Cho SY, Choi HY. Causes of death and metastatic patterns in patients with mammary cancer. Ten-year autopsy study. Am J Clin Pathol 1980; 73:232 - 4; PMID: 6243853
   PubMed Web of Science ®Google Scholar
• Pestalozzi BC, Zahrieh D, Price KN, Holmberg SB, Lindtner J, Collins J, Crivellari D, Fey MF, Murray E, Pagani O, et al, International Breast Cancer Study Group (IBCSG). Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol 2006; 17:935 - 44; http://dx.doi.org/10.1093/annonc/mdl064; PMID: 16603601
   PubMed Web of Science ®Google Scholar
• Hicks DG, Short SM, Prescott NL, Tarr SM, Coleman KA, Yoder BJ, Crowe JP, Choueiri TK, Dawson AE, Budd GT, et al. Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR. Am J Surg Pathol 2006; 30:1097 - 104; http://dx.doi.org/10.1097/01.pas.0000213306.05811.b9; PMID: 16931954
   PubMed Web of Science ®Google Scholar
• Arshad F, Wang L, Sy C, Avraham S, Avraham HK. Blood-brain barrier integrity and breast cancer metastasis to the brain. Patholog Res Int 2010; 2011:920509; PMID: 21253507
   PubMedGoogle Scholar
• Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis 2010; 37:13 - 25; http://dx.doi.org/10.1016/j.nbd.2009.07.030; PMID: 19664713
   PubMed Web of Science ®Google Scholar
• Wolburg H, Wolburg-Buchholz K, Kraus J, Rascher-Eggstein G, Liebner S, Hamm S, Duffner F, Grote EH, Risau W, Engelhardt B. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol 2003; 105:586 - 92; PMID: 12734665
   PubMed Web of Science ®Google Scholar
• Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003; 161:653 - 60; http://dx.doi.org/10.1083/jcb.200302070; PMID: 12743111
   PubMed Web of Science ®Google Scholar
• Lee BC, Lee TH, Avraham S, Avraham HK. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res 2004; 2:327 - 38; PMID: 15235108
   PubMed Web of Science ®Google Scholar
• Li YM, Pan Y, Wei Y, Cheng X, Zhou BP, Tan M, Zhou X, Xia W, Hortobagyi GN, Yu D, et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 2004; 6:459 - 69; http://dx.doi.org/10.1016/j.ccr.2004.09.027; PMID: 15542430
   PubMed Web of Science ®Google Scholar
• Mendes O, Kim HT, Stoica G. Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clin Exp Metastasis 2005; 22:237 - 46; http://dx.doi.org/10.1007/s10585-005-8115-6; PMID: 16158251
   PubMed Web of Science ®Google Scholar
• Tester AM, Waltham M, Oh SJ, Bae SN, Bills MM, Walker EC, Kern FG, Stetler-Stevenson WG, Lippman ME, Thompson EW. Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast cancer cells in nude mice. Cancer Res 2004; 64:652 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-0384-2; PMID: 14744781
   PubMed Web of Science ®Google Scholar
• Stark AM, Anuszkiewicz B, Mentlein R, Yoneda T, Mehdorn HM, Held-Feindt J. Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells. J Neurooncol 2007; 81:39 - 48; http://dx.doi.org/10.1007/s11060-006-9207-0; PMID: 16850107
   PubMedGoogle Scholar
• Singer SJ, Nicolson GL. The fluid mosaic model of the structure of cell membranes. Science 1972; 175:720 - 31; http://dx.doi.org/10.1126/science.175.4023.720; PMID: 4333397
   PubMed Web of Science ®Google Scholar
• Ipsen JH, Karlström G, Mouritsen OG, Wennerström H, Zuckermann MJ. Phase equilibria in the phosphatidylcholine-cholesterol system. Biochim Biophys Acta 1987; 905:162 - 72; http://dx.doi.org/10.1016/0005-2736(87)90020-4; PMID: 3676307
   PubMed Web of Science ®Google Scholar
• Karnovsky MJ, Kleinfeld AM, Hoover RL, Klausner RD. The concept of lipid domains in membranes. J Cell Biol 1982; 94:1 - 6; http://dx.doi.org/10.1083/jcb.94.1.1; PMID: 6889603
   PubMed Web of Science ®Google Scholar
• Lee AG, Birdsall NJ, Metcalfe JC, Toon PA, Warren GB. Clusters in lipid bilayers and the interpretation of thermal effects in biological membranes. Biochemistry 1974; 13:3699 - 705; http://dx.doi.org/10.1021/bi00715a013; PMID: 4368511
   PubMed Web of Science ®Google Scholar
• van Meer G, Poorthuis BJ, Wirtz KW, Op den Kamp JA, van Deenen LL. Transbilayer distribution and mobility of phosphatidylcholine in intact erythrocyte membranes. A study with phosphatidylcholine exchange protein. Eur J Biochem 1980; 103:283 - 8; http://dx.doi.org/10.1111/j.1432-1033.1980.tb04313.x; PMID: 7363893
   PubMedGoogle Scholar
• Stier A, Sackmann E. Spin labels as enzyme substrates. Heterogeneous lipid distribution in liver microsomal membranes. Biochim Biophys Acta 1973; 311:400 - 8; http://dx.doi.org/10.1016/0005-2736(73)90320-9; PMID: 4354130
   PubMed Web of Science ®Google Scholar
• Yu J, Fischman DA, Steck TL. Selective solubilization of proteins and phospholipids from red blood cell membranes by nonionic detergents. J Supramol Struct 1973; 1:233 - 48; http://dx.doi.org/10.1002/jss.400010308; PMID: 4804838
   PubMedGoogle Scholar
• Simons K, van Meer G. Lipid sorting in epithelial cells. Biochemistry 1988; 27:6197 - 202; http://dx.doi.org/10.1021/bi00417a001; PMID: 3064805
   PubMed Web of Science ®Google Scholar
• Pike LJ. Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J Lipid Res 2006; 47:1597 - 8; http://dx.doi.org/10.1194/jlr.E600002-JLR200; PMID: 16645198
   PubMed Web of Science ®Google Scholar
• Nusrat A, Parkos CA, Verkade P, Foley CS, Liang TW, Innis-Whitehouse W, Eastburn KK, Madara JL. Tight junctions are membrane microdomains. J Cell Sci 2000; 113:1771 - 81; PMID: 10769208
   PubMed Web of Science ®Google Scholar
• Li Q, Zhang Q, Zhang M, Wang C, Zhu Z, Li N, Li J. Effect of n-3 polyunsaturated fatty acids on membrane microdomain localization of tight junction proteins in experimental colitis. FEBS J 2008; 275:411 - 20; http://dx.doi.org/10.1111/j.1742-4658.2007.06210.x; PMID: 18167140
   PubMed Web of Science ®Google Scholar
• Sugibayashi K, Onuki Y, Takayama K. Displacement of tight junction proteins from detergent-resistant membrane domains by treatment with sodium caprate. Eur J Pharm Sci 2009; 36:246 - 53; http://dx.doi.org/10.1016/j.ejps.2008.09.011; PMID: 19013238
   PubMed Web of Science ®Google Scholar
• Lambert D, O’Neill CA, Padfield PJ. Methyl-beta-cyclodextrin increases permeability of Caco-2 cell monolayers by displacing specific claudins from cholesterol rich domains associated with tight junctions. Cell Physiol Biochem 2007; 20:495 - 506; http://dx.doi.org/10.1159/000107533; PMID: 17762176
   PubMed Web of Science ®Google Scholar
• Irwin ME, Bohin N, Boerner JL. Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells. Cancer Biol Ther 2011; 12:718 - 26; http://dx.doi.org/10.4161/cbt.12.8.16907; PMID: 21775822
   PubMed Web of Science ®Google Scholar
• Irwin ME, Mueller KL, Bohin N, Ge Y, Boerner JL. Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. J Cell Physiol 2011; 226:2316 - 28; http://dx.doi.org/10.1002/jcp.22570; PMID: 21660955
   PubMed Web of Science ®Google Scholar
• Hitosugi T, Sato M, Sasaki K, Umezawa Y. Lipid raft specific knockdown of SRC family kinase activity inhibits cell adhesion and cell cycle progression of breast cancer cells. Cancer Res 2007; 67:8139 - 48; http://dx.doi.org/10.1158/0008-5472.CAN-06-4539; PMID: 17804726
   PubMedGoogle Scholar
• Roura S, Miravet S, Piedra J, García de Herreros A, Duñach M. Regulation of E-cadherin/Catenin association by tyrosine phosphorylation. J Biol Chem 1999; 274:36734 - 40; http://dx.doi.org/10.1074/jbc.274.51.36734; PMID: 10593980
   PubMed Web of Science ®Google Scholar
• Biscardi JS, Ishizawar RC, Silva CM, Parsons SJ. Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer. Breast Cancer Res 2000; 2:203 - 10; http://dx.doi.org/10.1186/bcr55; PMID: 11250711
   PubMedGoogle Scholar
• Foley J, Nickerson NK, Nam S, Allen KT, Gilmore JL, Nephew KP, Riese DJ 2nd. EGFR signaling in breast cancer: bad to the bone. Semin Cell Dev Biol 2010; 21:951 - 60; http://dx.doi.org/10.1016/j.semcdb.2010.08.009; PMID: 20813200
   PubMedGoogle Scholar
• Solis GP, Lüchtenborg AM, Katanaev VL. Wnt secretion and gradient formation. Int J Mol Sci 2013; 14:5130 - 45; http://dx.doi.org/10.3390/ijms14035130; PMID: 23455472
   PubMedGoogle Scholar
• Katanaev VL, Solis GP, Hausmann G, Buestorf S, Katanayeva N, Schrock Y, Stuermer CA, Basler K. Reggie-1/flotillin-2 promotes secretion of the long-range signalling forms of Wingless and Hedgehog in Drosophila. EMBO J 2008; 27:509 - 21; http://dx.doi.org/10.1038/sj.emboj.7601981; PMID: 18219274
   PubMed Web of Science ®Google Scholar
• Mañes S, Mira E, Gómez-Moutón C, Lacalle RA, Keller P, Labrador JP, Martínez-A C. Membrane raft microdomains mediate front-rear polarity in migrating cells. EMBO J 1999; 18:6211 - 20; http://dx.doi.org/10.1093/emboj/18.22.6211; PMID: 10562533
   PubMed Web of Science ®Google Scholar
• Donatello S, Babina IS, Hazelwood LD, Hill AD, Nabi IR, Hopkins AM. Lipid raft association restricts CD44-ezrin interaction and promotion of breast cancer cell migration. Am J Pathol 2012; 181:2172 - 87; http://dx.doi.org/10.1016/j.ajpath.2012.08.025; PMID: 23031255
   PubMed Web of Science ®Google Scholar
• Ivanov AI. Pharmacological inhibition of endocytic pathways: is it specific enough to be useful?. Methods Mol Biol 2008; 440:15 - 33; http://dx.doi.org/10.1007/978-1-59745-178-9_2; PMID: 18369934
   PubMedGoogle Scholar
• Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A, et al, kConFab. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 2009; 15:907 - 13; http://dx.doi.org/10.1038/nm.2000; PMID: 19648928
   PubMed Web of Science ®Google Scholar
• Faria G, Cardoso MJ, Martins D, Bettencourt H, Amendoeira I, Schimitt F. P-cadherin as prognostic factor for loco-regional relapse in breast cancer. Acta Med Port 2012; 25:97 - 105; PMID: 22985920
   PubMed Web of Science ®Google Scholar
• Lipponen P, Saarelainen E, Ji H, Aaltomaa S, Syrjänen K. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol 1994; 174:101 - 9; http://dx.doi.org/10.1002/path.1711740206; PMID: 7965405
   PubMedGoogle Scholar
• Peralta Soler A, Knudsen KA, Salazar H, Han AC, Keshgegian AA. P-cadherin expression in breast carcinoma indicates poor survival. Cancer 1999; 86:1263 - 72; http://dx.doi.org/10.1002/(SICI)1097-0142(19991001)86:7<1263::AID-CNCR23>3.0.CO;2-2; PMID: 10506713
   PubMedGoogle Scholar
• Querzoli P, Coradini D, Pedriali M, Boracchi P, Ambrogi F, Raimondi E, La Sorda R, Lattanzio R, Rinaldi R, Lunardi M, et al. An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. Br J Cancer 2010; 103:1835 - 9; http://dx.doi.org/10.1038/sj.bjc.6605991; PMID: 21063415
   PubMedGoogle Scholar
• Eljuga D, Bulić K, Petrovečki M, Bali V, Ozimec E, Razumović JJ. Reduced E-cadherin expression is a predictor of lower overall survival and metastatic disease in invasive ductal breast cancer. Onkologie 2012; 35:414 - 8; http://dx.doi.org/10.1159/000341071; PMID: 22846972
   PubMedGoogle Scholar
• Singhai R, Patil VW, Jaiswal SR, Patil SD, Tayade MB, Patil AV. E-Cadherin as a diagnostic biomarker in breast cancer. N Am J Med Sci 2011; 3:227 - 33; http://dx.doi.org/10.4297/najms.2011.3227; PMID: 22558599
   PubMedGoogle Scholar
• Saadatmand S, de Kruijf EM, Sajet A, Dekker-Ensink NG, van Nes JG, Putter H, Smit VT, van de Velde CJ, Liefers GJ, Kuppen PJ. Expression of cell adhesion molecules and prognosis in breast cancer. Br J Surg 2013; 100:252 - 60; http://dx.doi.org/10.1002/bjs.8980; PMID: 23175431
   PubMedGoogle Scholar
• Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol 1998; 185:262 - 6; http://dx.doi.org/10.1002/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO;2-Y; PMID: 9771479
   PubMedGoogle Scholar
• López-Knowles E, Zardawi SJ, McNeil CM, Millar EK, Crea P, Musgrove EA, Sutherland RL, O’Toole SA. Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients. Cancer Epidemiol Biomarkers Prev 2010; 19:301 - 9; http://dx.doi.org/10.1158/1055-9965.EPI-09-0741; PMID: 20056651
   PubMedGoogle Scholar
• Katahira J, Sugiyama H, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N. Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J Biol Chem 1997; 272:26652 - 8; http://dx.doi.org/10.1074/jbc.272.42.26652; PMID: 9334247
   PubMed Web of Science ®Google Scholar
• Kominsky SL, Vali M, Korz D, Gabig TG, Weitzman SA, Argani P, Sukumar S. Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol 2004; 164:1627 - 33; http://dx.doi.org/10.1016/S0002-9440(10)63721-2; PMID: 15111309
   PubMed Web of Science ®Google Scholar
• Goetsch L, Haeuw JF, Beau-Larvor C, Gonzalez A, Zanna L, Malissard M, Lepecquet AM, Robert A, Bailly C, Broussas M, et al. A novel role for junctional adhesion molecule-A in tumor proliferation: modulation by an anti-JAM-A monoclonal antibody. Int J Cancer 2013; 132:1463 - 74; http://dx.doi.org/10.1002/ijc.27772; PMID: 22886345
   PubMed Web of Science ®Google Scholar
• Shintani Y, Fukumoto Y, Chaika N, Grandgenett PM, Hollingsworth MA, Wheelock MJ, Johnson KR. ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression. Int J Cancer 2008; 122:71 - 7; http://dx.doi.org/10.1002/ijc.23027; PMID: 17721921
   PubMed Web of Science ®Google Scholar
• Li H, Price DK, Figg WD. ADH1, an N-cadherin inhibitor, evaluated in preclinical models of angiogenesis and androgen-independent prostate cancer. Anticancer Drugs 2007; 18:563 - 8; http://dx.doi.org/10.1097/CAD.0b013e328020043e; PMID: 17414625
   PubMed Web of Science ®Google Scholar
• Perotti A, Sessa C, Mancuso A, Noberasco C, Cresta S, Locatelli A, Carcangiu ML, Passera K, Braghetti A, Scaramuzza D, et al. Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours. Ann Oncol 2009; 20:741 - 5; http://dx.doi.org/10.1093/annonc/mdn695; PMID: 19190075
   PubMed Web of Science ®Google Scholar